Conversations with Giants in Medicine
View all reviews...
Nephrology (Jun 2014)
Lymphatic Vasculature (Mar 2014)
Epigenetics in Cancer (Jan 2014)
Cancer Metabolism (Sep 2013)
Liver Repair and Regeneration (May 2013)
Aging (Mar 2013)
Cardiology (Jan 2013)
View all review series...
The Attending Physician
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
Marta Guix, Anthony C. Faber, Shizhen Emily Wang, Maria Graciela Olivares, Youngchul Song, Sherman Qu, Cammie Rinehart, Brenda Seidel, Douglas Yee, Carlos L. Arteaga, Jeffrey A. Engelman
Volume 118, Issue 7
J Clin Invest.
2008; 118(7):2609–2619 doi:10.1172/JCI34588
Full Text PDF |
Follow the JCI on:
Copyright © 2014
American Society for Clinical Investigation